Prostate Cancer News and Research

Latest Prostate Cancer News and Research

European approval for Taxotere (docetaxel) in prostate cancer

Aventis, part of the sanofi-aventis Group announced today that the European Commission has approved Taxotere (docetaxel) Injection Concentrate for use in combination with prednisone as a treatment for men with androgen-independent (hormone- refractory) metastatic prostate cancer.

4 Nov 2004

Study aims to improve information and support for older men with prostate cancer

The Centre for Health Services Studies (CHSS) at the University of Kent, England is currently engaged in an exploratory study of the information and support needs for men aged 75+ with prostate cancer.

4 Nov 2004

Landmark case challenges safety of Atkins diet

West Palm Beach County Court Judge Susan Lubitz ruled today that the landmark lawsuit filed by former Atkins dieter and Florida businessman Jody Gorran will go forward.

3 Nov 2004

Genetic link suggested in deaths from cardiac valve diseases

Deaths from cardiac valve diseases appear to run in families, suggesting a significant genetic component, according to a study published in Circulation: Journal of the American Heart Association.

2 Nov 2004

Scientists have found that a protein present in normal body tissues can prevent tumour growth

A team led by Dr Dave Bates, British Heart Foundation Lecturer, and Dr Steve Harper, Senior Research Fellow in the Microvascular Research Laboratories, in the Department of Physiology at Bristol University, have discovered that a type of vascular endothelial growth factor (VEGF) found in normal tissue, including blood, can prevent cancers from growing.

1 Nov 2004

Higher radiation doses helps patients with advanced non-small cell lung cancer live longer

Treating patients with advanced non-small cell lung cancer more aggressively by giving them higher doses of radiation helps keep the disease from spreading and allows some patients to live longer

28 Oct 2004

Men undergoing prostate cancer therapy forget things faster

Oregon Health & Science University researchers studying how testosterone deprivation affects verbal memory found that men undergoing the prostate cancer therapy forget things faster than their healthy counterparts.

25 Oct 2004

Blocking gene opens avenues for treating prostate cancer

Cancer Research UK scientists in Oxford have found a new way to make prostate cancer succumb more readily to currently used treatments.

22 Oct 2004

Discovery of new protein involved in regulating the second most commonly mutated tumor suppressor in human tumors

Scientists in Tokyo have discovered a new protein, named PICT-1, that is involved in regulating PTEN, the second most commonly mutated tumor suppressor in human tumors.

22 Oct 2004

Home defibrillators now being sold on Amazon.com

Royal Philips Electronics has announced that the Philips HeartStart Home Defibrillator is now available over-the-counter (OTC) to consumers at Amazon.com, the largest online retailer to offer the product.

22 Oct 2004

Cyclopamine, derived from the corn lily may treat and prevent basal cell carcinoma

Researchers at the University of Texas Medical Branch at Galveston (UTMB) have demonstrated in laboratory animals that a compound derived from a common plant can be used to treat and prevent the most widespread form of cancer in people

18 Oct 2004

Fruit and vitamin C intake are likely to be useful for the prevention of stomach cancer

The Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study was initiated to test the effect of vitamin supplementation on the prevention of lung and other cancers.

18 Oct 2004

Vitamin E's status as a super supplement questioned

Over the past decade, vitamin E has become one of the top-selling supplements in the United States, in part because research released in the early- to mid-1990s suggested that taking vitamin E supplements might protect against heart disease, boost the immune system and reduce the risk of macular degeneration.

14 Oct 2004

Black men have better sexual and urinary function than white men after prostate cancer surgery

Five years after surgery for prostate cancer, African-American men reported better sexual and urinary function than non-Latino white men-yet they were also more dissatisfied with problems related to their sexual function

13 Oct 2004

Paroxetine is an effective treatment for diminishing hot flashes in men who are receiving hormone therapy for prostate cancer

A new antidepressant medication is an effective treatment for diminishing hot flashes in men who are receiving hormone therapy for prostate cancer, Mayo Clinic researchers report in the October issue of Mayo Clinic Proceedings.

12 Oct 2004

Prostate cancer patients who no longer respond to hormone therapy may benefit from a combination of docetaxel and estramustine

Prostate cancer patients whose cancer has spread to other parts of the body and who no longer respond to hormone therapy may benefit from a combination of the cancer drugs docetaxel and estramustine, according to a new study published in the Oct. 8 issue of the New England Journal of Medicine.

8 Oct 2004

Men with advanced, incurable prostate cancer can benefit from docetaxel

An international study led by a Canadian researcher shows that men with advanced, incurable prostate cancer can survive an average of three months longer and face less symptoms when offered a new treatment for prostate cancer.

7 Oct 2004

Call for UK and Luxembourg governments to put access to quality cancer treatment at the top of their health agendas

Speaking today at a workshop on 'Cancer treatment: a priority for patients in Europe', cancer specialists and representatives of cancer patients called on the UK and Luxembourg governments to put access to quality cancer treatment at the top of their health agendas during their Presidencies of the EU in 2005.

7 Oct 2004

Breast cancer drug Taxotere extends life of prostate cancer patients

Men with androgen-independent (hormone-refractory) metastatic prostate cancer treated with the breast-cancer drug Taxotere (docetaxel) Injection Concentrate in combination with the drug estramustine survived 20 percent longer than similar patients receiving the standard therapy

6 Oct 2004

$10 million to establish a multidisciplinary research program in cancer nanotechnology

The National Institutes of Health (NIH) has awarded scientists from Emory University and the Georgia Institute of Technology two new collaborative research grants, totaling nearly $10 million, to establish a multidisciplinary research program in cancer nanotechnology and to develop a new class of nanoparticles for molecular and cellular imaging.

6 Oct 2004

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

European approval for Taxotere (docetaxel) in prostate cancer

Study aims to improve information and support for older men with prostate cancer

Landmark case challenges safety of Atkins diet

Genetic link suggested in deaths from cardiac valve diseases

Scientists have found that a protein present in normal body tissues can prevent tumour growth

Higher radiation doses helps patients with advanced non-small cell lung cancer live longer

Men undergoing prostate cancer therapy forget things faster

Blocking gene opens avenues for treating prostate cancer

Discovery of new protein involved in regulating the second most commonly mutated tumor suppressor in human tumors

Home defibrillators now being sold on Amazon.com

Cyclopamine, derived from the corn lily may treat and prevent basal cell carcinoma

Fruit and vitamin C intake are likely to be useful for the prevention of stomach cancer

Vitamin E's status as a super supplement questioned

Black men have better sexual and urinary function than white men after prostate cancer surgery

Paroxetine is an effective treatment for diminishing hot flashes in men who are receiving hormone therapy for prostate cancer

Prostate cancer patients who no longer respond to hormone therapy may benefit from a combination of docetaxel and estramustine

Men with advanced, incurable prostate cancer can benefit from docetaxel

Call for UK and Luxembourg governments to put access to quality cancer treatment at the top of their health agendas

Breast cancer drug Taxotere extends life of prostate cancer patients

$10 million to establish a multidisciplinary research program in cancer nanotechnology

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in